Prof. Dr. Evrim Metcalfe

Domaines d’intérêt médical indiqués par le médecin lui-même sur sa page du site de l’établissement. Source : medicana.com.tr.

Expérience

• 2006-2010Uzman, Samsun Eğitim ve Araştırma Hastanesi Radyasyon Onkolojisi Kliniği (zorunlu hizmet)medicana.com.tr
• 2010-2016Yardımcı Doçent, Radyasyon Onkolojisi Anabilim Dalı, Eskişehirmedicana.com.tr
• 2016-2021Doçent, Eskişehir Osmangazi Üniversitesi Tıp Fakültesi Radyasyon Onkolojisi Anabilim Dalı ve FMV Işık Üniversitesi MYOmedicana.com.tr
• 2021-2023Profesör, Biruni Üniversitesi Tıp Fakültesi Radyasyon Onkolojisi Anabilim Dalımedicana.com.tr
• 2023-2026Profesör, İstanbul Medipol Üniversitesi Radyasyon Onkolojisi Anabilim Dalımedicana.com.tr
• 2026-HalenProfesör, Medicana International İstanbul Hastanesimedicana.com.tr

Formation

• 1992-1998Ege Üniversitesi Tıp Fakültesimedicana.com.tr
• 2000-2006Dokuz Eylül Üniversitesi Tıp Fakültesi, Radyasyon Onkolojisimedicana.com.tr

• SpécialitéOncologie-radiothérapiemedicana.com.trD’après la source
• ÉtablissementMedicana International Istanbul - Beylikdüzümedicana.com.trD’après la source
• Publications21 publicationspage de profil sur medicana.com.trD’après la source
• Dernière synchronisation7 novembre 2026 03:25https://www.medicana.com.tr/hekim-detay/25698/evrim-metcalfemedicana.com.tr

1. Gorken IB, Bayman E, Balci P, et al. Comparing Ultrasound with Computerized Tomography Images to Choose Electron Energy for Radiotherapy Boost Field in Breast Cancer Patients with Breast Conserving Surgery. J BUON. 2010;15(3):500-503.

   Source : page de profil sur medicana.com.tr

2. Etiz D, Bayman E, Akcay M, et al. Dosimetric and Clinical Predictors of Acute Esophagitis in Lung Cancer Patients in Turkey Treated with Radiotherapy. Asian Pac J Cancer Prev. 2013;14(7):4223-4228.

   Source : page de profil sur medicana.com.tr

3. Etiz D, Ataizi FC, Bayman E, et al. Prognostic Value of Osteopontin in Patients Treated with Primary Radiotherapy for Head and Neck Cancer. Asian Pac J Cancer Prev. 2013;14(9):5175-5178.

   Source : page de profil sur medicana.com.tr

4. Erpolat OP, Alco G, Caglar HB, et al. Comparison of Hematologic Toxicity Between 3DCRT and IMRT Planning in Cervical Cancer Patients After Concurrent Chemoradiotherapy: A National Multi-Center Study. Eur J Gynaecol Oncol. 2014;35(1):62-66.

   Source : page de profil sur medicana.com.tr

5. Bayman E, Prestwich RJ, Speight R, et al. Patterns of Failure After Intensity-Modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma Using Compartmental Clinical Target Volume Delineation. Clin Oncol (R Coll Radiol). 2014;26(10):636-642.

   Source : page de profil sur medicana.com.tr

6. Bayman E, Etiz D, Akcay M, Ak G. Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution in Turkey. Asian Pac J Cancer Prev. 2014;15(15):6264-6267.

   Source : page de profil sur medicana.com.tr

7. Murray L, Sethugavalar B, Robertshaw H, Bayman E, et al. Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks. Clin Oncol (R Coll Radiol). 2015;27(7):401-410.

   Source : page de profil sur medicana.com.tr

8. Bird D, Scarsbrook AF, Sykes J, et al. Multimodality Imaging with CT, MR and FDG-PET for Radiotherapy Target Volume Delineation in Oropharyngeal Squamous Cell Carcinoma. BMC Cancer. 2015;15:844.

   Source : page de profil sur medicana.com.tr

9. Metcalfe E, Etiz D. Early Transient Radiation-Induced Brachial Plexopathy in Locally Advanced Head and Neck Cancer. Contemp Oncol (Pozn). 2016;20(1):67-72.

   Source : page de profil sur medicana.com.tr

10. Metcalfe E, Karaoglanoglu O, Akyazici E. Radiotherapy with or without Temozolomide in Elderly Patients Aged ≥70 Years with Glioblastoma. Contemp Oncol (Pozn). 2016;20(3):251-255.

    Source : page de profil sur medicana.com.tr